phase one clinical trial

Technology-based pharma company, Verseon, has submitted a Phase I clinical trial protocol for its lead precision oral anticoagulant (PROAC) — VE-1902 — to the Bellberry Human Research Ethics Committee (HREC) in Australia. Read more


Information has surfaced that suggests the drug, which caused the death of one person and the hospitalisation of five others, killed five dogs during a pre-clinical test Read more


One person has died and another five are in a serious condition after taking part in a French clinical drugs trial Read more